Risk factors
INSMED (INSM) risk factors
Item 1A of every INSMED Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors52 risks15 new4 dropped28 reworded
BRINSUPRI joins ARIKAYCE as an approved-product dependency, expanding market-acceptance and commercialization risk to both products.
Filed Feb 19, 2026 - FY2024 10-K risk factors40 risks
ARIKAYCE’s commercial acceptance and safety remain central, while brensocatib, TPIP and other pipeline programs face approval and development uncertainty.
Filed Feb 20, 2025